Lebanon Sci-Tech Weekly
SEE OTHER BRANDS

Following science and technology news from Lebanon

Lebanon Sci-Tech Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Lebanon Sci-Tech Weekly.

Press releases published on September 5, 2025

Orbit International Reports Consolidated Bookings of Approximately $2,400,000 for Month of August
Cellectar Biosciences to Participate in Multiple Upcoming Medical Meetings and Industry Conferences in September
Banzai Completes $32.7 Million Debt and Liability Elimination Through August 31, 2025
Tiziana Life Sciences Announces Purchase of Shares by Chairman
24/7 Market News: Kraig Labs Fibers are 5X Stronger Than Steel, Tougher than Kevlar, and Biodegradable
Lowkick Studio Launches $SHARDS as WorldShards Expands to Global Audiences
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
electroCore Announces Departure of Peter Cuneo from the Board of Directors and Elects Thomas J. Errico, MD as Chairman of the Board
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension at World Sleep 2025
Geotab atinge 5 milhões de veículos conectados globalmente e reforça liderança em telemática
Youxin Technology Ltd Announces Pricing of $6.0 Million Underwritten Public Offering
Firefly Neuroscience Partners with HealingMaps to Offer Cognitive Electrophysiology Analytics to Over 2,500 Ketamine, Psilocybin, and TMS Clinics Across North America
Blocksize Exposes Hidden Custodial Staking Risks, Calls for Transparency and Governance to Secure Solana’s Future
Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy
NextGen Digital Platforms Inc. Appoints Mark Creaser to Advisory Board
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update
Theratechnologies annonce la disponibilité d’EGRIFTA WR (MC) (tésamoréline) pour injection pour la réduction de l’excès de graisse abdominale chez les adultes vivant avec le VIH atteints de lipodystrophie
uniQure Announces Initial AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions